$174 Million is the total value of WEALTH EFFECTS LLC's 191 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FBT | FIRST TR EXCHANGE-TRADED FDny arca biotech | $596,791 | +16.8% | 3,872 | 0.0% | 0.34% | +8.9% | |
| WTRG | ESSENTIAL UTILS INC | $543,273 | +15.3% | 11,382 | 0.0% | 0.31% | +7.6% | |
| MRNA | MODERNA INC | $425,879 | +52.1% | 2,371 | 0.0% | 0.24% | +42.1% | |
| RNP | COHEN & STEERS REIT & PFD & | $403,537 | +5.1% | 19,801 | 0.0% | 0.23% | -2.1% | |
| DHR | DANAHER CORPORATION | $397,164 | +2.9% | 1,496 | 0.0% | 0.23% | -3.8% | |
| HOLX | HOLOGIC INC | $374,050 | +15.8% | 5,000 | 0.0% | 0.21% | +8.1% | |
| SPY | SPDR S&P 500 ETF TRtr unit | $374,737 | +7.1% | 980 | 0.0% | 0.21% | 0.0% | |
| CSX | CSX CORP | $305,029 | +16.4% | 9,846 | 0.0% | 0.17% | +8.8% | |
| LMT | LOCKHEED MARTIN CORP | $294,326 | +25.8% | 605 | 0.0% | 0.17% | +17.5% | |
| EPD | ENTERPRISE PRODS PARTNERS L | $283,004 | +1.4% | 11,733 | 0.0% | 0.16% | -5.3% | |
| CMI | CUMMINS INC | $244,763 | +18.8% | 1,010 | 0.0% | 0.14% | +11.1% | |
| FXU | FIRST TR EXCHANGE TRADED FDutilities alph | $242,367 | +8.7% | 7,298 | 0.0% | 0.14% | +1.5% | |
| FXH | FIRST TR EXCHANGE TRADED FDhlth care alph | $238,033 | +11.8% | 2,189 | 0.0% | 0.14% | +4.6% | |
| DVY | ISHARES TRselect divid etf | $235,773 | +12.3% | 1,955 | 0.0% | 0.14% | +5.5% | |
| PMD | PSYCHEMEDICS CORP | $218,263 | -24.0% | 44,501 | 0.0% | 0.12% | -29.0% | |
| FXN | FIRST TR EXCHANGE TRADED FDenergy alphadx | $179,445 | +9.4% | 10,500 | 0.0% | 0.10% | +2.0% | |
| IBRX | IMMUNITYBIO INC | $144,495 | +1.8% | 28,500 | 0.0% | 0.08% | -5.7% | |
| ET | ENERGY TRANSFER L P | $118,700 | +7.9% | 10,000 | 0.0% | 0.07% | +1.5% | |
| ICCC | IMMUCELL CORP | $95,465 | -18.4% | 15,650 | 0.0% | 0.05% | -25.0% | |
| ISR | ISORAY INC | $27,181 | +8.7% | 110,000 | 0.0% | 0.02% | +6.7% | |
| AKBA | AKEBIA THERAPEUTICS INC | $10,568 | +76.1% | 18,316 | 0.0% | 0.01% | +50.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-02
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AVADEL PHARMACEUTICALS PLC | 8 | Q3 2023 | 17.2% |
| APPLE INC | 8 | Q3 2023 | 9.6% |
| AMAZON COM INC | 8 | Q3 2023 | 4.5% |
| NVIDIA CORPORATION | 8 | Q3 2023 | 5.1% |
| MICROSOFT CORP | 8 | Q3 2023 | 3.3% |
| ARROWHEAD PHARMACEUTICALS IN | 8 | Q3 2023 | 4.0% |
| JPMORGAN CHASE & CO | 8 | Q3 2023 | 2.4% |
| ALPHABET INC | 8 | Q3 2023 | 2.3% |
| THE TRADE DESK INC | 8 | Q3 2023 | 2.3% |
| FIRST TR EXCHANGE-TRADED FD | 8 | Q3 2023 | 2.4% |
View WEALTH EFFECTS LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-22 |
| 13F-HR | 2024-01-29 |
| 13F-HR | 2023-10-16 |
| 13F-HR | 2023-07-18 |
| 13F-HR | 2023-05-04 |
| 13F-HR | 2023-02-02 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-09 |
View WEALTH EFFECTS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.